Bajer L, Polakovicova P, Heczkova M, Holm K, Hole MJ, Hlavaty M, Bohdanecka A, Drastich P, Tichanek F, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Jørgensen KK, Brezina J, Macinga P, Wohl P, Fabian O, Hov JR, Cahova M (2025)
Geography-independent mucosal microbiota alterations in primary sclerosing cholangitis persist after liver transplantation
JHEP Rep, 8 (4), 101716
DOI 10.1016/j.jhepr.2025.101716, PubMed 41951277

Bergsmark C, Kristensen VA, Sjåmo MB, Høivik ML, Anisdahl K (2026)
Therapeutic drug monitoring in inflammatory bowel disease patients switching from intravenous to subcutaneous infliximab: insights from a prospective real-world study
Scand J Gastroenterol, 1-11 (in press)
DOI 10.1080/00365521.2026.2645083, PubMed 41902476

Johansen I, Hagen MC, Løkkeberg ST, Aabrekk TB, Asak Ø, Bengtson MB, Boyar R, Detlie TE, Frigstad SO, Aass Holten KI, Hovde Ø, Hüppert-Hauss G, Lund C, Medhus AW, Olsen BC, Strande V, Torp R, Vatn S, Høivik ML, Kristensen V, Jelsness-Jørgensen LP, Opheim R (2026)
Anxiety and depression in newly diagnosed patients with inflammatory bowel disease (the IBSEN III study) compared with the general population in Norway
J Crohns Colitis, 20 (3)
DOI 10.1093/ecco-jcc/jjag021, PubMed 41824394